AMAG Pharmaceuticals (AMAG)
20.80
-0.45 -2.12%
NASDAQ
Apr 18, 20:00
Delayed 2m
USD
View All Key Stats
AMAG Key Stats
| Income Statement | |
| Revenue (TTM) | 609.94M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.68 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -199.23M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 51.83% |
| Profit Margin (Quarterly) | 2.19% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 709.05M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 1.190 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.8973 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 74.64M |
| Return on Equity (TTM) | Upgrade |
View All AMAG News
AMAG News
-
WireHeadlineTime (ET)
-
Yahoo04/10 15:17
-
Yahoo03/29 09:20
-
MT Newswires03/26 10:38
-
SA Breaking News03/26 09:57
-
PR Newswire03/26 08:00
-
Globe Newswire03/26 08:00
-
MT Newswires03/23 15:07
-
SA Breaking News03/23 09:27
-
SA Breaking News03/09 10:02
-
SA Breaking News03/09 09:59
View All Events
AMAG Events
| Date | Type | Description |
|---|---|---|
| 05/02/2018 | Misc | AMAG Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/02/2018 | Earnings | AMAG Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 03/01/2018 | Misc | AMAG Pharmaceuticals Inc Annual Report in 2017 |
| 02/27/2018 08:00 EST | Misc | AMAG Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 02/27/2018 | Earnings | AMAG Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017 |
| 11/02/2017 08:00 EDT | Misc | AMAG Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 11/02/2017 | Earnings | AMAG Pharmaceuticals Inc Third Quarter Earnings in 2017 Release |
| 08/03/2017 08:00 EDT | Misc | AMAG Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | AMAG Pharmaceuticals Inc Second Quarter Earnings in 2017 Release |
| 05/24/2017 08:30 EDT | Misc | AMAG Pharmaceuticals, Inc. Analyst Day |
AMAG Fundamentals
Income Statement View Statement
AMAG Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
AMAG One Page Reports
- One Page Report Download
AMAG Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 20.80 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.amagpharma.com
- Investor Relations URL: http://ir.amagpharma.com/phoenix.zhtml?c=61596&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: May. 02, 2018
- Last Earnings Release: Feb. 27, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.
AMAG Excel Add-In Codes
- Name: =YCI("AMAG","name")
- Description: =YCI("AMAG","description")
- Sector: =YCI("AMAG","sector")
- Industry: =YCI("AMAG","industry")
- Est. Current Fiscal Year End: =YCI("AMAG","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other AMAG Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- AMAG Tweets Stocktwits
Advertisement
